Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $45,002 | 27 | 33.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,887 | 22 | 23.2% |
| Food and Beverage | $24,820 | 1,424 | 18.7% |
| Consulting Fee | $22,961 | 12 | 17.3% |
| Travel and Lodging | $9,282 | 33 | 7.0% |
| Education | $121.60 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $38,104 | 110 | $0 (2023) |
| UCB, Inc. | $28,560 | 146 | $0 (2024) |
| Amgen Inc. | $16,714 | 218 | $0 (2024) |
| Horizon Pharma plc | $14,976 | 48 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $14,849 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $4,302 | 122 | $0 (2024) |
| PFIZER INC. | $3,320 | 126 | $0 (2024) |
| ABBVIE INC. | $3,290 | 201 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,723 | 126 | $0 (2024) |
| Gilead Sciences, Inc. | $1,335 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,218 | 208 | Amgen Inc. ($14,179) |
| 2023 | $19,113 | 215 | Horizon Therapeutics plc ($9,765) |
| 2022 | $15,114 | 201 | Horizon Therapeutics plc ($8,785) |
| 2021 | $14,614 | 164 | UCB, Inc. ($6,333) |
| 2020 | $8,505 | 143 | UCB, Inc. ($3,601) |
| 2019 | $18,064 | 178 | Horizon Therapeutics plc ($11,659) |
| 2018 | $17,452 | 220 | Horizon Pharma plc ($14,849) |
| 2017 | $11,994 | 198 | E.R. Squibb & Sons, L.L.C. ($9,649) |
All Payment Transactions
1,527 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $48.38 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $43.05 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $297.48 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $84.92 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $58.24 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | Cash or cash equivalent | $9.13 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | Cash or cash equivalent | $5.93 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 11/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $123.25 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 5,741 | 41,760 | $3.6M | $624,190 |
| 2022 | 49 | 6,457 | 40,347 | $3.5M | $590,944 |
| 2021 | 47 | 4,978 | 13,874 | $2.2M | $336,900 |
| 2020 | 41 | 2,874 | 8,542 | $1.2M | $191,210 |
All Medicare Procedures & Services
184 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 110 | 10,261 | $656,640 | $189,623 | 28.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 25 | 21,840 | $458,640 | $172,039 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 481 | $302,549 | $43,724 | 14.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 197 | 300 | $235,500 | $40,628 | 17.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 37 | 351 | $330,556 | $20,141 | 6.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 114 | 114 | $125,286 | $18,464 | 14.7% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 149 | 1,044 | $233,856 | $18,345 | 7.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 19 | 97 | $182,748 | $9,932 | 5.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 287 | 342 | $125,822 | $9,921 | 7.9% |
| 86481 | Tuberculosis test, enumeration of t-cells | Office | 2023 | 94 | 99 | $81,477 | $9,702 | 11.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 45 | 196 | $95,648 | $8,024 | 8.4% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 25 | 119 | $55,578 | $6,875 | 12.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 342 | 656 | $79,365 | $6,790 | 8.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 362 | 730 | $46,714 | $6,132 | 13.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $54,704 | $5,835 | 10.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 95 | 185 | $49,765 | $5,095 | 10.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 69 | $32,499 | $4,538 | 14.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 304 | 553 | $51,420 | $4,208 | 8.2% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 155 | 312 | $45,240 | $3,526 | 7.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 213 | 227 | $11,118 | $3,355 | 30.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 173 | 185 | $6,845 | $3,045 | 44.5% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 302 | 548 | $36,162 | $2,784 | 7.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 149 | 237 | $37,446 | $2,587 | 6.9% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2023 | 149 | 149 | $25,628 | $2,007 | 7.8% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 154 | 154 | $24,332 | $1,954 | 8.0% |
About Dr. Omar Khan, DO
Dr. Omar Khan, DO is a Internal Medicine healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1144480310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omar Khan, DO has received a total of $133,075 in payments from pharmaceutical and medical device companies, with $28,218 received in 2024. These payments were reported across 1,527 transactions from 50 companies. The most common payment nature is "Honoraria" ($45,002).
As a Medicare-enrolled provider, Khan has provided services to 20,050 Medicare beneficiaries, totaling 104,523 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 184 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Cumming, GA
- Active Since 06/11/2008
- Last Updated 05/23/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1144480310
Products in Payments
- KRYSTEXXA (Biological) $48,558
- KRYSTEXXA (Drug) $14,940
- Cimzia (Drug) $12,422
- ORENCIA (Biological) $11,691
- Bimzelx (Biological) $10,538
- TREMFYA (Drug) $3,595
- XELJANZ (Drug) $2,973
- Enbrel (Biological) $2,033
- RINVOQ (Biological) $1,656
- COSENTYX (Biological) $1,412
- SKYRIZI (Biological) $731.91
- EVENITY (Biological) $676.20
- TALTZ (Drug) $549.20
- BENLYSTA (Biological) $463.81
- Humira (Biological) $447.94
- OFEV (Drug) $446.32
- Rituxan (Biological) $329.16
- REMICADE (Biological) $310.63
- KEVZARA (Drug) $302.12
- SIMPONI ARIA (Biological) $297.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cumming
Carlos Calle-Muller
Internal Medicine — Payments: $27,324
Chunzhi Xia
Internal Medicine — Payments: $20,579
Otto Goyco
Internal Medicine — Payments: $15,121
Jennifer Cook, Md, MD
Internal Medicine — Payments: $14,871
Anjali Dua, M.d, M.D
Internal Medicine — Payments: $13,465
Dr. Dana Eilen
Internal Medicine — Payments: $11,621